Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Annuities > Variable Annuities

Lawsky fines Axa $20M for annuity changes

By Zachary Tracer

X
Your article was successfully shared with the contacts you provided.

(Bloomberg) – Axa SA’s U.S. unit was fined $20 million by a New York regulator for making changes to a retirement product without fully informing the watchdog.

Axa Equitable changed the investment strategy for some variable annuities sold earlier, limiting potential returns for customers without providing adequate notice to regulators, the New York Department of Financial Services said today in a statement.

“Axa changed the rules on these important products midstream,” Superintendent of Financial Services Benjamin Lawsky said in the statement. “When it comes to retirement products, insurers must go above and beyond to explain any changes that would alter investor returns.”

Axa said in a statement that it routinely makes changes to products and that policyholders have a “full menu” of investment options. The company said the regulator found that it “should have communicated better to NYDFS when it made certain technical filings.”

Variable annuities can guarantee that a client’s account will appreciate even if assets decline in value.Axa, based in Paris, applied a strategy called Axa Tactical Manager to some accounts, which was designed to smooth returns in volatile markets, DFS said.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.